col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Virus Research
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―24 Structural modelling of SARS-CoV-2 new variant (B.1.1.7) suggests enhanced furin binding and infectivity Anwar Mohammad, Jehad Abubaker, Fahd Al-Mulla
2 [GO] 2021―Jun―17 A novel RdRp-based colorimetric RT-LAMP assay for rapid and sensitive detection of SARS-CoV-2 in clinical and sewage samples from Pakistan Muhammad Farhan Ul Haque, Syeda Sadia Bukhari, Rabia Ejaz, Faheem Uz Zaman, Kamalalayam Rajan Sreejith, Naeem Rashid, et al. (+2)
3 [GO] 2021―Jun―10 Positive Selection as a Key Player for SARS-CoV-2 Pathogenicity: Insights into ORF1ab, S and E genes Mohamed Emam, Mariam Oweda, Agostinho Antunes, Mohamed El-Hadidi
4 [GO] 2021―Jun―09 Zoonotic and Reverse Zoonotic Transmissibility of SARS-CoV-2 Iryna V. Goraichuk, Vasiliy Arefiev, Borys T. Stegniy, Anton P. Gerilovych
5 [GO] 2021―Jun―06 The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models Kim M. Stegmann, Antje Dickmanns, Sabrina Gerber, Vella Nikolova, Luisa Klemke, Valentina Manzini, et al. (+12)
6 [GO] 2021―Jun―01 Viral Vector DNA- and RNA-Based SARS-CoV-2 Vaccines: Possible Integration into the Human Genome Are Adenoviral Genes Expressed in Vector-based Vaccines? Walter Doerfler
7 [GO] 2021―May―29 Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism Martine Policard, Sidharth Jain, Samantha Rego, Sivanesan Dakshanamurthy
8 [GO] 2021―May―17 The COVID-19 Vaccine Development: A Pandemic Paradigm Diego C. Carneiro, Jéssica D. Sousa, Joana P. Monteiro-Cunha
9 [GO] 2021―May―05 Epitope mapping of severe acute respiratory syndrome-related coronavirus nucleocapsid protein with a rabbit monoclonal antibody Xingui Tian, Chuncong Mo, Liling Zhou, Yujie Yang, Zhichao Zhou, Aiping You, et al. (+4)
10 [GO] 2021―Apr―30 Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV-2 Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy
11 [GO] 2021―Apr―30 Implications in the quantification of SARS-CoV2 copies in concurrent nasopharyngeal swabs, whole mouth fluid and respiratory droplets Priya Kannian, Bagavad Gita Jayaraman, Swarna Alamelu, Chandra Lavanya, Nagalingeswaran Kumarasamy, Gunaseelan Rajan, et al. (+6)
12 [GO] 2021―Apr―15 Quantifying the effect of trypsin and elastase on in vitro SARS-CoV infections Thalia Rodriguez, Hana M. Dobrovolny
13 [GO] 2021―Apr―06 SARS-CoV-2 presented moderately during two episodes of the infection with lack of antibody responses Mostafa Salehi-Vaziri, Mir Davood Omrani, Mohammad Hassan Pouriayevali, Fatemeh Fotouhi, Mohammad Banifazl, Behrokh Farahmand, et al. (+6)
14 [GO] 2021―Mar―27 Genome-wide Analysis of 10664 SARS-CoV-2 Genomes to Identify Virus Strains in 73 Countries based on Single Nucleotide Polymorphism Nimisha Ghosh, Indrajit Saha, Nikhil Sharma, Suman Nandi, Dariusz Plewczynski
15 [GO] 2021―Mar―20 Novel indel mutation in the N gene of SARS-CoV-2 clinical samples that were diagnosed positive in a commercial RT-PCR assay Sanghoo Lee, DongJu Won, Chang-Ki Kim, Jinwoo Ahn, Youngkee Lee, Hyeongkyun Na, et al. (+5)
16 [GO] 2021―Mar―18 Global and Local Mutations in Bangladeshi SARS-CoV-2 Genomes Md. Mahbub Hasan, Rasel Das, Md. Rasheduzzaman, Md. Hamed Hussain, Nazmul Hasan Muzahid, Asma Salauddin, et al. (+4)
17 [GO] 2021―Mar―08 Virucidal activity of slightly acidic hypochlorous acid water toward influenza virus and coronavirus with tests simulating practical usage Yu Miyaoka, Humayun Kabir, Amirul Hasan, Makiko Yamaguchi, Dany Shoham, Harumi Murakami, Kazuaki Takehara
18 [GO] 2021―Mar―08 Clinical and molecular aspects of veterinary coronaviruses S.E. Colina, M.S. Serena, M.G. Echeverría, G.E. Metz
19 [GO] 2021―Feb―22 Protection against COVID-19 in African population: Immunology, genetics, and malaria clues for therapeutic targets Marcos Altable, Juan Moisés de la Serna
20 [GO] 2021―Feb―22 Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil Ronaldo da Silva Francisco, L. Felipe Benites, Alessandra P. Lamarca, Luiz G.P. de Almeida, Alana Witt Hansen, Juliana Schons Gularte, et al. (+17)
21 [GO] 2021―Feb―21 The ORF8 Protein of SARS-CoV-2 Induced Endoplasmic Reticulum Stress and Mediated Immune Evasion by Antagonizing Production of Interferon Beta Farooq Rashid, Emmanuel Enoch Dzakah, Haiying Wang, Shixing Tang
22 [GO] 2021―Feb―15 Misinterpretation of viral load in COVID-19 clinical outcomes Renan Lyra Miranda, Alexandro Guterres, Carlos Henrique de Azeredo Lima, Paulo Niemeyer Filho, Mônica R. Gadelha
23 [GO] 2021―Jan―19 The 442th amino acid residue of the spike protein is critical for the adaptation to bat hosts for SARS-related coronaviruses Jin-Yan Li, Qiong Wang, Ce-Heng Liao, Ye Qiu, Xing-Yi Ge
24 [GO] 2021―Jan―19 A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein Roy Sylvie, Karim Ghani, Pedro O. de Campos-Lima, Manuel Caruso
25 [GO] 2021―Jan―11 CRISPR systems: Novel approaches for detection and combating COVID-19 Fatemeh Safari, Mohammad Afarid, Banafsheh Rastegari, Afshin Borhani-Haghighi, Mazyar Barekati-Mowahed, Abbas Behzad-Behbahani
26 [GO] 2021―Jan―11 Tmprss2 specific miRNAs as promising regulators for SARS-CoV-2 entry checkpoint Taruneet Kaur, Suman Kapila, Rajeev Kapila, Sandeep Kumar, Divya Upadhyay, Manjeet Kaur, Chandresh Sharma
27 [GO] 2021―Jan―08 Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19) Carolina Scagnolari, Alessandra Pierangeli, Federica Frasca, Camilla Bitossi, Agnese Viscido, Giuseppe Oliveto, et al. (+11)
28 [GO] 2020―Dec―16 A retrospective comparison of drugs against COVID-19 Jiahong Tan, Yuan Yuan, Cheng Xu, Chunyan Song, Dan Liu, Ding Ma, Qinglei Gao
29 [GO] 2020―Dec―10 COVID-19 infection in Hokkaido, Japan might depend on the viscosity of atmospheric air Yukinori Akiyama, Kyoya Sakashita, Masayasu Arihara, Yusuke Kimura, Katsuya Komatsu, Takeshi Mikami, Nobuhiro Mikuni
30 [GO] 2020―Nov―26 The DHODH Inhibitor PTC299 Arrests SARS-CoV-2 Replication and Suppresses Induction of Inflammatory Cytokines Jeremy Luban, Rachel Sattler, Elke Mühlberger, Jason D. Graci, Liangxian Cao, Marla Weetall, et al. (+17)
31 [GO] 2020―Nov―21 Putative Roles of Vitamin D in Modulating Immune Response and Immunopathology Associated With COVID-19 Raman Kumar, Afrozul Haq, Sunil J. Wimalawansa, Alpana Sharma
32 [GO] 2020―Nov―21 Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a Khajohn Joonlasak, Elizabeth M Batty, Theerarat Kochakarn, Bhakbhoom Panthan, Krittikorn Kümpornsin, Poramate Jiaranai, et al. (+15)
33 [GO] 2020―Nov―13 Trends of 2019-nCoV in South Asian Countries and Prediction of the Epidemic Peaks Abdul Malek, Ashabul Hoque
34 [GO] 2020―Nov―06 Deletion in the C-terminal region of the envelope glycoprotein in some of the Indian SARS-CoV-2 genome Ballamoole Krishna Kumar, Anusha Rohit, Kattapuni Suresh Prithvisagar, Praveen Rai, Indrani Karunasagar, Iddya Karunasagar
35 [GO] 2020―Oct―25 Ozone Therapy in COVID-19: a Narrative Review Francesco Cattel, Susanna Giordano, Cecilia Bertiond, Tommaso Lupia, Silvia Corcione, Matilde Scaldaferri, et al. (+2)
36 [GO] 2020―Oct―18 Nitric oxide (NO) and nanoparticles - potential small tools for the war against COVID-19 and other human coronavirus infections Joana C. Pieretti, Olga Rubilar, Richard B. Weller, Gonzalo R. Tortella, Amedea B. Seabra
37 [GO] 2020―Oct―16 The role of dysregulated immune responses in COVID-19 pathogenesis S Tahaghoghi-Hajghorbani, P Zafari, E Masoumi, M Rajabinejad, R Jafari-Shakib, B Hasani, A Rafiei
38 [GO] 2020―Oct―08 Anti-Inflammatory Drugs and the Renin-Angiotensin-Aldosterone System: Current Knowledge and Potential Effects on Early SARS-CoV-2 Infection Iris Louise N. Cabbab, Rafael Vincent M. Manalo
39 [GO] 2020―Sep―25 Transcription-based drug repurposing for COVID-19 Richard Killick, Clive Ballard, Patrick Doherty, Gareth Williams
40 [GO] 2020―Sep―24 "Sample pooling of RNA extracts to speed up SARS-CoV-2 diagnosis using CDC FDA EUA RT-qPCR kit" Byron Freire-Paspuel, Patricio Vega-Mariño, Alberto Velez, Marilyn Cruz, Miguel Angel Garcia-Bereguiain
41 [GO] 2020―Sep―24 Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world Stefanie Weber, Christina Ramirez, Walter Doerfler
42 [GO] 2020―Sep―24 Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection Prashant Khare, Utkarsha Sahu, Satish Chandra Pandey, Mukesh Samant
43 [GO] 2020―Sep―23 IFN-γ is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection Ana Carolina Gadotti, Marina de Castro Deus, Joao Paulo Telles, Rafael Wind, Marina Goes, Roberta Garcia Charello Ossoski, et al. (+5)
44 [GO] 2020―Sep―09 The role of Host Genetics in susceptibility to severe viral infections in humans and INSIGHTS into host genetics of severe COVID-19: A systematic review Abdelazeem Elhabyan, Saja El Yaacoub, Ehab Sanad, Abdelwahab Mohamed, Asmaa Elhabyan, Valentin Dinu
45 [GO] 2020―Sep―09 SARS-CoV-2 host tropism: an in silico analysis of the main cellular factors H.R. Rangel, J.T. Ortega, S. Maksoud, F.H. Pujol, M.L. Serrano
46 [GO] 2020―Aug―29 Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19 Shalki Choudhary, Om Silakari
47 [GO] 2020―Aug―28 Association of vitamin D with the modulation of the disease severity in COVID-19 R. Mardani, A. Alamdary, S.D. Mousavi Nasab, R. Gholami, N. Ahmadi, A. Gholami
48 [GO] 2020―Aug―28 Fecal viral shedding in COVID-19 patients: clinical significance, viral load dynamics and survival analysis Xiaoming Wang, Jingwei Zheng, Lei Guo, Hao Yao, Lingya Wang, Xia XiaoDong, Weixi Zhang
49 [GO] 2020―Aug―23 Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development Subodh Kumar Samrat, Anil M. Tharappel, Zhong Li, Hongmin Li
50 [GO] 2020―Aug―19 Effect of Remdesivir on Patients with COVID-19: A Network Meta-Analysis of Randomized Control Trials Yujiro Yokoyama, Alexandros Briasoulis, Hisato Takagi, Toshiki Kuno
51 [GO] 2020―Aug―18 iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2 Zahir Ali, Rashid Aman, Ahmed Mahas, Gundra Sivakrishna Rao, Muhammad Tehseen, Tin Marsic, et al. (+13)
52 [GO] 2020―Aug―13 COVID-19 Vaccine: A comprehensive status report Simran Preet Kaur, Vandana Gupta
53 [GO] 2020―Aug―07 Analysis of codon usage of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) and its adaptability in dog Rupam Dutta, Lukumoni Buragohain, Probodh Borah
54 [GO] 2020―Aug―05 Melatonin potentials against viral infections including COVID-19: current evidence and new findings Kobra Bahrampour Juybari, Mohammad Hossein Pourhanifeh, Azam Hosseinzadeh, Karim Hemati, Saeed Mehrzadi
55 [GO] 2020―Jul―28 100 Days of Solitude: The spring of COVID-19 through the eyes of 15 young virologists of the INITIATE program Zsofia Keszei, Xavier Martinez Vendrell, Maria Soultsioti, Pau Ribo Molina, Lorenz Wirth, H. Weiss, et al. (+11)
56 [GO] 2020―Jul―24 Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy Taj Mohammad, Anas Shamsi, Saleha Anwar, Afzal Hussain, Md. Tabish Rehman, Mohamed F. AlAjmi, et al. (+2)
57 [GO] 2020―Jul―24 Immunological co-ordination between gut and lungs in SARS-CoV-2 infection Shruti Ahlawat, Krishna Kant Sharma
58 [GO] 2020―Jul―17 Phylogenetic and phylodynamic analyses of SARS-CoV-2 Qing Nie, Xingguang Li, Wei Chen, Dehui Liu, Yingying Chen, Haitao Li, et al. (+4)
59 [GO] 2020―Jul―03 The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide Yukitaka Yamasaki, Seido Ooka, Tomoya Tsuchida, Yuta Nakamura, Yuta Hagiwara, Yoshiyuki Naitou, et al. (+13)
60 [GO] 2020―Jul―01 Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2 Li Lin, Sun Ting, He Yufei, Li Wendong, Fan Yubo, Zhang Jing
61 [GO] 2020―Jun―24 Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection Chang Li, Lin Wang, Linzhu Ren
62 [GO] 2020―Jun―23 The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway Jin-Yan Li, Ce-Heng Liao, Qiong Wang, Yong-Jun Tan, Rui Luo, Ye Qiu, Xing-Yi Ge
63 [GO] 2020―Jun―20 COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking Giuseppe Magro
64 [GO] 2020―Jun―18 Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors Alice Romeo, Federico Iacovelli, Mattia Falconi
65 [GO] 2020―Jun―09 Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China Xiaoqi Pan, Lan Dong, Nian Yang, Dayi Chen, Cheng Peng
66 [GO] 2020―Jun―09 Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein Nouredine Behloul, Sarra Baha, Ruihua Shi, Jihong Meng
67 [GO] 2020―Jun―06 Clinical features of discharged COVID-19 patients with an extended SARS-CoV-2 RNA positive signal in respiratory samples Jiajun Li, Xiaoyu Wei, Wenguang Tian, Jingbo Zou, Yue Wang, Wei Xue, et al. (+2)
68 [GO] 2020―Jun―02 Clinical features of familial clustering in patients infected with 2019 novel coronavirus in Wuhan, China Jinzhong Li, Xiaobing Gong, Zhigang Wang, Renzhou Chen, Taoyuan Li, Dongyu Zeng, Minran Li
69 [GO] 2020―May―21 Sodium status and kidney involvement during COVID-19 infection Adrian Post, Robin P.F. Dullaart, Stephan J.L. Bakker
70 [GO] 2020―May―16 Swine enteric alphacoronavirus (swine acute diarrhea syndrome coronavirus): an update three years after its discovery Yong-Le Yang, Jia-Qi Yu, Yao-Wei Huang
71 [GO] 2020―May―15 COVID-19: CADD to the rescue Abdulmujeeb T. Onawole, Kazeem O. Sulaiman, Temitope U. Kolapo, Fatimo O. Akinde, Rukayat O. Adegoke
72 [GO] 2020―May―15 On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2 Carolina Corrêa Giron, Aatto Laaksonen, Fernando L. Barroso da Silva
73 [GO] 2020―May―13 Gut microbiota and Covid-19- possible link and implications Debojyoti Dhar, Abhishek Mohanty
74 [GO] 2020―May―04 The impacts of viral inactivating methods on quantitative RT-PCR for COVID-19 Yueying Wang, Wei Song, Zuguo Zhao, Ping Chen, Jian Liu, Chende Li
75 [GO] 2020―Apr―30 Natural product-derived phytochemicals as potential agents against coronaviruses: a review Janice S. Mani, Joel B. Johnson, Jason C. Steel, Daniel A. Broszczak, Paul M. Neilsen, Kerry B. Walsh, Mani Naiker
76 [GO] 2020―Apr―12 A COMPREHENSIVE ANALYSIS OF GENOME COMPOSITION AND CODON USAGE PATTERNS OF EMERGING CORONAVIRUSES Fernando L. Tort, Matías Castells, Juan Cristina
77 [GO] 2020―Apr―02 Integrin β3, a RACK1 interacting protein, is critical for porcine reproductive and respiratory syndrome virus infection and NF-κB activation in Marc-145 cells Chao Yang, Rui Lan, Xiaochun Wang, Qian Zhao, Xidan Li, Junlong Bi, et al. (+5)
78 [GO] 2019―Dec―26 Swine acute diarrhea syndrome coronavirus (SADS-CoV) antagonizes interferon-β production via blocking IPS-1 and RIG-I Zhihai Zhou, Yuan Sun, Xiaoling Yan, Xiaoyu Tang, Qianniu Li, Yaorong Tan, et al. (+2)


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.006 sec